The impact of phosphate lowering agents on clinical and laboratory outcomes in chronic kidney disease patients: a systematic review and meta-analysis of randomized controlled trials.

Jeerath PhannajitNatthaphon WonghakaeoKullaya TakkavatakarnThanin AsawavichienjindaKearkiat PraditpornsilpaSomchai Eiam-OngPaweena Susantitaphong

Published in: Journal of nephrology (2021)

In addition to decreasing serum phosphate levels, various beneficial effects on clinical and laboratory parameters of phosphate lowering agents might play potential roles in diminishing morbidity and mortality in CKD patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
peritoneal dialysis
type diabetes
metabolic syndrome
adipose tissue
weight loss